Serum Albumin and Natural Products

Progress in Biological Chirality

Volumn , Issue , 2004, Pages 271-295

  Di Bari, Lorenzo ^a   Ripoli, Silvia ^a   Salvadori, Piero ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77951519087     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-008044396-6/50025-3     Document Type: Chapter

References (68)

1. Some common abbreviations found in the literature: HSA human serum albumin, BSA bovine serum albumin, OA ovalbumin, rHA recombinant HSA.
2. Carter D.C., Ho J.X. Structure of serum albumin. Adv. Prot. Chem. 1994, 153-203.
3. He X.-M., Carter D.C. Atomic structure and chemistry of human serum albumin. Nature 1992, 358:209-215.
4. Harder S., Thurmann P. Clinically important drug interactions with anticoagulants: an update. Clin. Pharmacokinet. 1996, 30:416-444.
5. Oravcová J., Böhs B., Lindner W. New drug-protein binding studies trends in analytical and experimental methodology. J. Chromatogr. B 1996, 677:1-28.
6. Hage D.S., Tweed S.A. Recent advances in chromatographic and electrophoretic methods for the study of drug-protein interactions. J. Chromatogr. B 1997, 699:499-525.
7. Bertucci C., Domenici E. Reversible and covalent binding of drugs to human serum albumin: methodological approaches and physiological relevance. Current Medic. Chem. 2002, 9:1463-1481.
8. Ascoli G., Bertucci C., Salvadori P. Stereospecific and competitive binding of drugs to human serum albumin: a difference circular dichroism approach. J. Pharm. Sci. 1995, 84:737-741.
9. Klotz I.M., Walker F.M., Pivan R.B. The binding of organic ions by proteins. J. Am. Chem. Soc. 1946, 68:1486-1489.
10. Jansen J.Aa. Kinetics of the binding of salicylazosulfapyridine to human serum albumin. Acta Pharmacol. Toxicol. 1977, 41:401-416.
11. Keita Y., Worner W., Veile G., Woodcock B.G., Fuhr U. Influence of non-steroidal anti-inflammatory drugs on the binding kinetics of dansylsarcosine to human serum albumin-stereoselectivity, steric and inductive effects. Arzn. Forsch. Res. 1996, 46:164-168.
12. Roberts J.R., Xiao J., Schleisman B., Parsons D.J., Shaw C.F. Kinetics and mechanism of the reaction between serum albumin and auranofin (and its isopropyl analogue) in vitro. Inorg. Chem. 1996, 35:424-433.
13. Xu Y., Tang P., Firestone L., Zhang T.T. F-19 nuclear magnetic resonance investigation of stereoselective binding of isoflurane to bovine serum albumin. Biophys. 1996, 70:532-538.
14. Lozinsky E., Novoselsky A., Glaser R., Shames A.I., Likhtenshtein G.I., Meyerstein D. Effect of ionic strength on the binding of ascorbate to albumin. Biochim. Biophys. Acta Biomembranes 2002, 1571:239.
15. Peters T., Meyer B. NMR spectroscopy of proteins. Angew. Chem., Int. Ed. 2003, 42:864-890.
16. De Wolf F.A., Brett G.M. Ligand-binding proteins: their potential for application in systems for controlled delivery and uptake of ligands. Pharmacol. Rev. 2000, 52:207-236.
17. Jung D.M., De Ropp J.S., Ebeller S.E. Application of pulsed field gradient NMR techniques for investigating binding of flavor compounds to macromolecules. J. Agric. Food Chem. 2002, 50:4262-4269.
18. Damodaran S., Kinsella J.E. Flavor protein interactions. Binding of carbonyls to bovine serum albumin: thermodynamic and conformational effects. J. Agric. Food Chem. 1980, 28:567-571.
19. Burova T.V., Grinberg N.V., Grinberg V.Y., Tolstoguzov V.B. Binding of odorants to individual proteins and their mixtures. Effects of protein denaturation and association. A plasticized globule state. Colloids and Surfaces A: Physicochem. Eng. Aspects 2003, 213:235-244.
20. McMasters D.R., Vedani A. Ochratoxin binding to phenylalanyl-tRNA synthetase: computational approach to the mechanism of ochratoxins and its antagonism. J. Med. Chem. 1999, 42:3075-3086.
21. Il'ichev Y.V., Perry J.L., Simon J.D. Interaction of ochratoxin A with human serum albumin. Preferential binding of dianion and pH effects. J. Phys. Chem. B 2002, 106:452-459.
22. Il'ichev Y.V., Perry J.L., Simon J.D. Interaction of ochratoxin A with human serum albumin. A common binding site of ochratoxin A and warfarin in subdomain IIA. J. Phys. Chem. B 2002, 106:460-465.
23. Perry J.L., Il'ichev Y.V., Kempf V.R., McClendon J., Park G., Manderville R.A., Rûker F., Dockal M., Simon J.D. Binding of ochratoxin A derivatives to human serum albumin. J. Phys. Chem. B 2003, 107:6644-6647.
24. Tsutsumi Y., Maruyama T., Takadate A., Goto M., Matsunaga H., Otagiri M. Interaction between two dicarboxylate endogenous substances, bilirubin and an uremic toxin, 3-carboxy-4-methyl-5-propyl-2-furanpropanoic acid, on human serum albumin. Pharm. Res. 1999, 16:916-923.
25. Sakai T., Yamasaki K., Sajo T., Kragh-Hansen U., Suenaga A., Otagiri M. Interaction mechanism between indoxyl sulfate, a typical uremic toxin bound to site II, and ligands bound to site I of human serum albumin. Pharm. Res. 2001, 18:520-524.
26. The Falvonoids 1975, Chapman and Hall Ltd, N.Y. J.B. Harborne, T.J. Mabry, H. Mabry (Eds.).
27. Cook N.C., Samman S. Flavonoids-chemistry, metabolism, cardioprotective effects, and dietary sources. Nutr. Biochem. 1996, 7:66-76.
28. Dangles O., Dufour C., Manach C., Morand C., Remesy C. Binding of flavonoids to plasma proteins. Methods Enzymol. 2001, 335:319-333.
29. Hollman P.C.H., Gaag M.V.D., Mengelers M.J.B., van Trijp J.M.P., de Vries J.H.M., Katan M.B. Absorption and disposition kinetics of the dietary antioxidant quercetin in man. Free Radical Biol. Med. 1996, 21:703-707.
30. Hollman P.C.H., Katan M.B. Dietary flavonoids: intake, health effects and bioavailability. Food. Chem. Toxicol. 1999, 37:937-942.
31. Arts J.T.J., Haenen G.R.M.M., Voss H.-P., Bast A. Masking of antioxidant capacity by the interaction of flavonoids with proteins. Food. Chem. Toxicol. 2001, 39:787-791.
32. Arts J.T.J., Haenen G.R.M.M., Wilms L.C., Beetstra S.A.J.N., Heijnen C.G.M., Voss H.-P., Bast A. Interactions between flavonoids and proteins: effect on the total antioxidant capacity. J. Agric. Food Chem. 2002, 50:1184-1187.
33. Zsila F., Bikádi Z., Simonyi M. Probing the binding of the flavonoid, quercetin to human serum albumin by circular dichroism, electronic absorption spectroscopy and molecular modelling methods. Biochem. Pharmacol. 2003, 65:447-456.
34. Simonyi M., Bikádi Z., Zsila F., Deli J. Supramolecular excition chirality of carotenoid aggregates. Chirality 2003, 15:680-698.
35. Zsila F., Bikádi Z., Simonyi M. Induced chirality upon crocetin binding to human serum albumin: origin and nature. Tetrahedron: Asymmetry 2001, 12:3125-3137.
36. Zsila F., Simonyi M., Lockwood S.F. Interaction of the disodium disuccinate derivative of mesoastaxanthin with human serum albumin: from chiral complexation to self-assembly. Bioorg. Med. Chem. Lett. 2003, 13:4093-4100.
37. Bhattacharya A.A., Grûne T., Curry S. Crystallographic analysis reveals common modes of binding of medium and long-chain fatty acids to human serum albumin. J. Mol. Biol. 2000, 303:721-732.
38. Noctor T.A.G., Wainer I.W. Allosteric and competitive displacement of drugs from human serum albumin by octanoic acid, as revealed by high-performance liquid chromatography, on a human serum albumin-based stationary phase. J. Chromat. B 1992, 577:305-315.
39. Gryzuno Y.A., Arroyo A., Vigne J.-L., Zhao Q., Tyurin V.A., Hubel C.A., Gandley R.E., Vladimirov Y.A., Taylor R.N., Kagan V.E. Binding of fatty acids facilitates oxidation of cysteine-34 and converts copper-albumin complexes from antioxidants to prooxidants. Archives Biochem. Biophys. 2003, 413:53-66.
40. Bertucci C., Canepa A., Ascoli G.A., Guimaraes L.F.L., Felix G. Site I on human albumin: differences in the binding of (R)- and (S)-warfarin. Chirality 1999, 11:675-679.
41. Ouchi A., Zandomeneghi G., Zandomeneghi M. Complexation of chiral aromatic substrates and their chemistry in ground and excited states. Catalytic and chirality recognition properties of the protein in the cases of binaphthol, its photoisomers and ketoprofen. Chirality 2002, 14:1-11.
42. Rodger A., Nordén B. Circular dichorism and linear dichroism 1997, Oxford University Press, Oxford (UK).
43. Berova N., Nakanishi K., Woody R.W. Circular dichroism principles and applications 2000, Wiley-VCH, New York (US).
44. Rosen A. The measurement of binding constants using circular dichroism. Binding of phenylbutazone and oxyphenbutazone. Biochem. Pharmacol. 1970, 19:2075-2081.
45. Bertucci C., Domenici E., Salvadori P. Stereochemical features of 1,4-benzodiazepin-2-ones bound to human serum albumin: difference CD and UV studies. Chirality 1990, 2:167-174.
46. Gaudreau S., Neault J.F., Tajmir-Riahi H.A. Interaction of AZT with human serum albumin studied by capillary electrophoresis, FTIR and CD spectroscopic methods. J. Biomol. Struct. Dynam. 2002, 19:1007-1014.
47. Kelly S.M., Price N.C. The use of circular dichroism in the investigation of protein structure and function. Current Protein and Peptide Science 2000, 1:349-384.
48. G. Pescitelli, D. Drochner, N. Berova and K. Nakanishi, unpublished results.
49. 19F NMR investigation. J. Pharm. Biomed. Anal. 1995, 13:1087-1093.
50. Lo L.-C., Liao Y.-C., Kuo C.H., Chen C.T. A novel coumarine-type derivatizing reagent of alcohols: application in the CD exciton chirality method for microscale structural determination. Org. Lett. 2000, 2:683-685.
51. Lightner D.A., Wijekoon W.M., Zhang M.-H. Understanding bilirubin conformation and binding. J. Biol. Chem. 1988, 263:16669-16676.
52. Puzicha C., Pu Y.-M., Lightner D.A. Allosteric regulation of conformational enantiomerism. Bilirubin. J. Am. Chem. Soc. 1991, 113:3583-3592.
53. Boiadjiev S.E., Lightner D.A. Optical activity and stereochemistry of linear oligopyrroles and bile pigments. Tetrahedron Asvmmetry 1999, 10:607-655.
54. Zsila F., Bikádi Z., Simonyi M. Unique pH-dependent biphasic band shape of the visible circular dichroism of curcumin-serum albumin complex. Biochem. Biophys. Res. Commun. 2003, 301:776-782.
55. Zsila F., Bikádi Z., Simonyi M. Molecular basis of the Cotton effects induced by the binding of curcumin to human serum albumin. Tetrahedron Asymmetry 2003, 14:2433-2444.
56. Reddy A.C.P., Sudharshan E., Rao A.G.A., Lokesh B.R. Interaction of curcumin with human serum albumin-A spectroscopic study. Lipids 1999, 34:1025-1029.
57. Zsila F., Bikádi Z., Simonyi M. Induced chirality upon crocetin binding to human serum albumin: origin and nature. Tetrahedron Asymmetry 2001, 12:3125-3137.
58. Price W.S. Recent advances in NMR diffusion techniques for studying drug binding. Aust. J. Chem. 2003, 36:855-860.
59. Dalvit C., Flocco M., Stockman B.J., Veronesi M. Competition Binding Experiments for Rapidly Ranking Lead Molecules for their Binding Affinity to Human Serum Albumin. Comb. Chem. High Throughput Screen. 2002, 5:645-650.
60. Chen A., Shapiro M.J. NOE Pumping: a novel NMR technique for identification of compounds with binding affinity to macromolecules. J. Am. Chem. Soc. 1998, 120:10258-10259.
61. Chen A., Shapiro M.J. NOE Pumping. 2. A high-throughput method to determine compounds with binding affinity to macromolecules by NMR. J. Am. Chem. Soc. 2000, 122:414-415.
62. Jung D.M., De Ropp J., Ebeler S.A. Application of Pulsed Field Gradient NMR Techniques for Investigating Binding of Flavor Compounds to Macromolecules. J. Agric. Food Chem. 2002, 50:4262-4269.
63. Minunni M. Biosensors based on nucleic acid interactions. Spectroscopy 2003, 17:613-625.
64. Mao Y., Wei W., He D., Nie L., Yao S. Monitoring and kinetic parameter estimation for the binding process of berberine hydrochloride to bovine serum albumin with piezoelectric quartz crystal impedance analysis. Anal. Biochem. 2002, 306:23-30.
65. Lyle E.L., Hayward G.L., Thompson M. Acoustic coupling of transverse waves as a mechanism for label-free detection of protein-small molecule interactions. Analyst 2002, 127:1596-1600.
66. Frostell-Karlsson ., Remaeus A., Roos H., Andersson K., Borg P., Hämäläinen M., Karlsson R. Biosensor analysis of the interaction between immobilized human serum albumin and drug compounds for ediction of human serum albumin binding levels. J. Med. Chem. 2000, 43:1986-1992.
67. Rich R.L., Day Y.S.L., Morton T.A., Myszka D.G. High-resolution and high-throughput protocols for measuring drug/human serum albumin interactions using BIACORE. Anal. Biochem. 2001, 296:197-207.
68. Bertucci C., Cimitan S. Rapid screening of small ligand affinity to human serum albumin by an optical biosensor. J. Pharm. Biomed. Anal. 2003, 32:707-714.